February 21, 2020 – Funding

The DF/HCC Lymphoma and Myeloma Program has released RFA's for its Myeloma SPORE Career Enhancement and Developmental Research Project Awards, with applications due on March 20, 2020. Read more about these awards below...

February 18, 2020

In this DF/HCC eNews Spotlight Edition, we present the DF/HCC Medicinal Chemistry Core which assists with all aspects of small molecule drug discovery, from the provision of suitable tool compounds to interrogate basic...

February 18, 2020 – Clinical Trials Research Informatics Office

OHRS and ODQ present a live broadcast presentation on Secondary Use and NHSR determinations. This is a broadcast presentation – there is no in-person session to attend. Pre-registration is not required.

February 18, 2020 – Funding

The DF/HCC - UMass Boston U54 Partnership has released a new Request for Applications!

February 11, 2020 – Event Highlight

Share your unique perspective as we work together to increase access to cancer care for all people affected by mental illness and their caregivers. Together, we can build a coalition with the power to save lives and...

January 30, 2020 – Funding

Dear Colleagues, This year’s NCI Provocative Questions have just been published. I’ve listed the questions themselves below and have attached a file with the questions along with the intent paragraph to let you...

January 28, 2020 – PRMS

We wanted to provide an update on the Dana Farber / Harvard Cancer Center clinical trial support system. As you know, over the summer, we launched iRIS, an online submission and review system.

January 15, 2020 – Funding

DF/HCC has received from NCI three separate P30 supplement opportunities in AIDS-related malignancies with pre-application deadline of 2/14, and full, invited application deadline of 3/31.

January 10, 2020 – PRMS

Please review the following tips and tricks that the iRIS team has gathered to help you to interact with the system better.

January 10, 2020 – PRMS

The application for Secondary Use, Medical Record Review, and Non-Human Subject Research Determination have been simplified to include only the regulatory questions needed for such submissions and no longer require a...